Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conference
Conference CoverageConference Listing
Publication
More
CME/CE
Partners
Resources
Interactive ToolsSpecial ProjectsSponsored
Contribute
Antibiotics Deconstructed
Clinical Forum Insights

Subscribe

  • News
  • Watch
  • Conference
  • Publication
  • CME/CE
  • Partners
  • Resources
  • Contribute
  • Subscribe
  • Clinical Forum Insights
  • Antimicrobial Stewardship
  • Blood-Borne Diseases
    • Ebola
    • HCV / Hepatitis
  • Coronavirus / COVID
  • Food Borne Infection / Food Safety
    • E. Coli
    • Food Safety
    • Listeria
    • Salmonella
  • Fungal Infections
    • Candida auris
  • Gastrointestinal Infections
    • C. Difficile
    • H. Pylori
    • Norovirus
  • Healthcare Associated Infections (HAI)
  • Prevention
    • Antibiotics
    • Immunizations
    • Vaccines
  • Respiratory Infections
    • Community-Acquired Pneumonia
    • Measles
    • Influenza
  • Sexually Transmitted Diseases
    • HIV / AIDS
    • HPV
    • HSV
    • PrEP
  • Skin & Soft Tissue Diseases
    • MRSA
  • Zoonotic & Vector-Borne Diseases
    • Lyme Disease
    • ZIKA
Spotlight -
Vaccines in America|
Antibiotics Deconstructed|
Bench to Bedside With SIDP|
Antimicrobial Stewardship|
Hepatitis
Advertisement

Christina G. Rivera, PharmD, BCPS

Advertisement

Articles by Christina G. Rivera, PharmD, BCPS

ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

ByChristina G. Rivera, PharmD, BCPS
April 18th 2019

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.

Advertisement

Latest Updated Articles

  • ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients
    ID Consultation Associated With Reductions in ED Visits, Hospital Admissions, and Cost for OPAT Patients

    April 18th 2019



Advertisement
Advertisement

Trending on Contagion Live

1

Washington State Reports First US Avian Influenza Death of 2026

2

Nearly 30% of US Adults Report Misrepresenting Symptoms to Get Antibiotics

3

FDA Tentatively Approves First Generic Lenacapavir PrEP for 120 LMICs

4

FDA Approves Voceryq, First Plasmid DNA Immunotherapy for Recurrent Respiratory Papillomatosis

5

Cefiderocol Activity Improves in Physiologic Media, Synergizes With LL-37

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us